Wells Fargo & Company Immunocore Holdings PLC Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
150Shares Held
39.3MCall Options Held
157KPut Options Held
139K-
Wellington Management Group LLP Boston, MA6.38MShares$219 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$167 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$103 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$97.2 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$84.8 Million0.06% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.51B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...